respiratori
tract
site
entri
mani
pathogen
first
line
defenc
prevent
colonis
respiratori
epithelium
consist
physic
measur
ciliari
clearanc
well
antimicrobi
substanc
airway
secret
respiratori
epitheli
cell
produc
antimicrobi
peptid
defensin
form
import
part
innat
immun
respons
respiratori
tract
diamond
et
al
singh
et
al
defensin
famili
cation
peptid
produc
neutrophil
macrophag
epitheli
cell
divid
b
u
theta
defensin
accord
structur
properti
ganz
human
bdefensin
show
direct
inhibitori
activ
virus
hiv
influenza
viru
leikina
et
al
quinonesmateu
et
al
well
bacteria
e
coli
staphylococcu
aureu
krishnakumari
et
al
addit
bdefensin
immunostimulatori
function
includ
chemotaxi
activ
antigenpres
cell
ganz
canin
genom
put
bdefensin
identifi
similar
search
canin
bdefensin
detect
rang
tissu
includ
lung
shown
inhibit
growth
gramposit
gramneg
bacteria
sang
et
al
two
defensin
found
canin
skin
howev
antimicrobi
properti
potenti
presenc
canin
respiratori
tract
investig
infecti
respiratori
diseas
common
health
problem
hous
dog
vaccin
frequent
provid
suffici
rapid
immun
respons
prevent
infect
dog
enter
kennel
tradit
canin
parainfluenza
viru
cpiv
canin
adenoviru
type
bacterium
bordetella
bronchiseptica
associ
bdefensin
cation
peptid
form
part
innat
immun
respons
respiratori
epithelium
due
antimicrobi
properti
immunostimulatori
activ
bdefensin
potenti
tool
treatment
prevent
respiratori
diseas
dog
infecti
respiratori
diseas
common
problem
particularli
hous
anim
studi
aim
assess
presenc
four
bdefensin
canin
respiratori
tract
use
quantit
realtim
pcr
determin
mrna
level
follow
microbi
challeng
three
bdefensin
detect
respiratori
cell
three
defensin
also
readili
express
skin
sampl
express
lymphoid
tissu
kidney
low
inconsist
treatment
primari
tracheal
epitheli
cell
lipopolysaccharid
lp
infect
canin
respiratori
coronaviru
led
decreas
express
cell
infect
canin
parainfluenza
viru
lower
level
furthermor
demonstr
antimicrobi
activ
respiratori
pathogen
bordetella
bronchiseptica
elsevi
bv
right
reserv
canin
infecti
respiratori
diseas
cird
includ
vaccin
diseas
complex
buonavoglia
martella
jacob
et
al
howev
everincreas
number
pathogen
includ
virus
bacteria
shown
present
diseas
complex
chalker
et
al
chalker
et
al
crawford
et
al
erl
et
al
bdefensin
may
offer
novel
rout
prevent
treatment
diseas
includ
cird
act
antimicrobi
either
topic
applic
upregul
defensin
product
host
cell
act
mediat
stimul
innat
immun
respons
addit
natur
occur
artifici
cation
peptid
may
use
vaccin
adjuv
charoenvit
et
al
fritz
et
al
studi
therefor
investig
presenc
bdefensin
canin
respiratori
tract
regul
follow
microbi
challeng
determin
antimicrobi
action
respiratori
pathogen
b
bronchiseptica
rna
extract
cdna
synthesi
rna
extract
cell
use
rneasi
kit
qiagen
crawley
follow
manufactur
protocol
cultur
cell
rna
elut
ml
rnasefre
water
genom
dna
remov
digest
rqdnase
promega
southampton
min
revers
transcript
perform
use
ml
rna
mg
random
hexam
ge
healthcar
littl
chalfont
ml
impromii
revers
transcriptas
promega
mgcl
concentr
mm
total
reaction
volum
ml
total
cdna
quantifi
use
quantit
tm
picogreen
assay
kit
invitrogen
paisley
select
detect
dsdna
dnarna
hybrid
cdna
sevil
et
al
assay
perform
use
modif
previous
publish
protocol
whelan
et
al
briefli
l
dna
standard
dilut
dilut
seri
mgml
ngml
cdna
sampl
test
duplic
final
dilut
fluoresc
measur
use
spectramax
plate
reader
molecular
devic
wokingham
excit
nm
emiss
nm
linear
standard
curv
construct
l
dna
standard
concentr
vs
fluoresc
unit
concentr
cdna
calcul
linear
equat
adjust
dilut
sequenc
intron
span
primer
cdna
given
tabl
pcr
carri
use
taq
polymeras
promega
final
concentr
mm
mgcl
condit
pcr
follow
initi
denatur
min
cycl
min
final
extens
min
pcr
product
analys
agaros
gel
visualis
ethidium
bromid
expect
product
size
bp
bp
bp
bp
pcr
product
clone
pgemt
easi
vector
promega
submit
sequenc
servic
univers
dunde
uk
confirm
integr
clone
bdefensin
pcr
product
clone
pgemt
easi
use
gener
standard
curv
dilut
seri
plasmid
dna
copiesml
prepar
use
produc
standard
curv
realtim
pcr
perform
use
sybr
green
jumpstart
taq
readi
mix
sigma
gillingham
final
concentr
mm
primer
mm
mgcl
mm
mgcl
mm
mgcl
respect
reaction
ml
cdna
templat
standard
ad
total
reaction
volum
ml
sampl
analys
duplic
run
standard
dilut
seri
includ
triplic
cycl
condit
min
follow
cycl
follow
extens
melt
step
perform
plate
read
taken
follow
melt
curv
analysi
min
reanneal
step
min
reaction
perform
dna
engin
opticon
biorad
hemel
hempstead
analys
copi
number
linear
regress
melt
curv
analysi
perform
experi
use
opticon
monitor
softwar
version
biorad
quantit
data
normal
cdna
concentr
dog
receiv
uk
rehom
centr
euthanis
due
behaviour
concern
unsuit
abil
rehom
whole
trachea
larynx
carina
asept
remov
necropsi
within
h
death
trachea
wash
briefli
steril
pb
wash
twice
h
dulbecco
modifi
eagl
medium
dmem
contain
mgml
gentamycin
uml
penicillin
mgml
streptomycin
mg
ml
amphotericin
b
sigma
tracheal
tissu
screen
contamin
respiratori
virus
mycoplasma
pcr
bacteri
contamin
cultur
blood
agar
plate
bectondickinson
oxford
pcr
assay
detect
canin
adenoviru
type
canin
herpesviru
canin
parainfluenza
viru
cpiv
canin
respiratori
coronaviru
crcov
canin
distemp
viru
mycoplasma
spp
perform
previous
describ
erl
et
al
erl
et
al
frisk
et
al
kobayashi
et
al
dna
extract
use
dneasi
tissu
kit
qiagen
accord
manufactur
instruct
rna
extract
cdna
synthesi
perform
describ
epitheli
cell
obtain
incub
complet
trachea
night
proteinas
type
xiv
sigma
concentr
mgml
pb
paa
yeovil
follow
proteinas
treatment
foetal
calf
serum
fc
ad
final
concentr
cell
harvest
centrifug
g
min
cell
pellet
one
trachea
resuspend
complet
dmemham
contain
fc
paa
mgml
gentamycin
uml
penicillin
mgml
streptomycin
mgml
amphotericin
b
cell
incub
tissu
cultur
flask
h
co
allow
fibroblast
settl
supernat
contain
epitheli
cell
seed
onto
four
plate
coat
collagen
type
bectondickinson
cell
maintain
experi
carri
co
confluent
cultur
ctec
deriv
one
dog
treat
e
coli
lp
sigma
mgml
complet
dmemham
h
h
control
cultur
incub
medium
confluent
cultur
infect
crcov
cpiv
multipl
infect
h
preliminari
experi
use
crcov
shown
chang
bdefensin
mrna
level
h
h
h
wherea
chang
observ
h
h
analysi
crcov
infect
cell
deriv
two
differ
dog
use
analys
h
h
cpivinfect
cultur
analys
h
prevent
cell
loss
due
cytopath
effect
tissu
sampl
two
dog
use
assess
mrna
level
canin
bdefensin
sampl
includ
trachea
skin
lung
palatin
tonsil
bronchial
lymph
node
spleen
liver
kidney
duodenum
jejunum
ileum
colon
mesenter
lymph
node
rna
extract
cdna
synthesi
perform
describ
bacteri
cultur
b
bronchiseptica
isol
obtain
dog
respiratori
diseas
grown
bordetgeng
agar
plate
bectondickinson
chalker
et
al
bacteria
quantifi
plate
serial
dilut
bordetgeng
agar
peptid
aa
synthesis
ppr
ltd
wickham
peptid
lyophilis
convert
hcl
salt
peptid
dissolv
dmso
concentr
mgml
peptid
dilut
sodium
phosphat
buffer
spb
ph
work
concentr
mgml
mgml
mgml
peptid
stock
dissolv
dmso
concentr
dmso
mgml
dilut
therefor
dmso
spb
use
neg
control
ml
dilut
dmso
ad
duplic
well
microtitr
plate
ml
b
bronchiseptica
cfu
spb
ad
incub
peptid
control
h
dilut
prepar
spb
plate
onto
bordetgeng
agar
plate
quadrupl
incub
h
number
coloni
determin
inhibit
activ
peptid
nacl
determin
mgml
mgml
peptid
concentr
mm
mm
nacl
concentr
assay
carri
nacl
ad
peptid
dilut
obtain
final
concentr
mm
mm
addit
bacteri
suspens
mean
standard
deviat
calcul
differ
experiment
group
assess
mannwhitney
test
use
spss
version
softwar
differ
consid
statist
signific
p
convent
pcr
use
determin
presenc
four
bdefensin
canin
trachea
found
present
wherea
tracheal
sampl
well
ctec
neg
express
therefor
analys
quantiti
mrna
determin
quantit
pcr
untreat
ctec
mrna
level
found
highest
averag
level
copi
per
ng
cdna
time
point
assess
averag
copi
number
copi
per
ng
cdna
copi
per
ng
cdna
compar
differ
ctec
prepar
mean
copi
number
rang
copi
per
ng
cdna
copi
per
ng
copi
per
ng
mrna
level
also
analys
within
prepar
untreat
primari
cell
time
level
increas
time
wherea
level
decreas
level
remain
rel
stabl
tabl
mrna
level
remain
unchang
h
follow
lp
treatment
p
h
level
lpstreat
cell
reduc
compar
control
cell
fig
reduct
statist
signific
p
small
increas
detect
h
lpstreat
cell
h
fig
chang
mrna
level
statist
signific
p
respect
level
mrna
found
unchang
lpstreat
cell
h
p
h
level
lpstreat
cell
lower
compar
control
cell
p
fig
effect
lp
treatment
product
tnfa
assess
h
h
fig
time
point
lpstreat
cell
increas
level
tnfa
compar
untreat
control
cell
p
time
point
follow
infect
crcov
level
decreas
h
p
h
p
fig
mrna
level
reduc
h
p
unchang
h
p
fig
level
mrna
decreas
h
p
decreas
h
p
fig
analysi
earlier
time
point
h
h
h
postinfect
show
chang
mrna
level
bdefensin
follow
crcovinfect
data
shown
follow
cpiv
infect
chang
detect
level
p
fig
level
fig
fig
reduc
respect
p
lung
spleen
liver
mesenter
lymph
node
small
larg
intestin
neg
convent
well
qpcr
three
bdefensin
detect
trachea
skin
use
convent
pcr
fig
well
qpcr
addit
peak
detect
qpcr
palatin
tonsil
bronchial
lymph
node
one
dog
convent
pcr
bronchial
lymph
node
sampl
neg
detect
palatin
tonsil
kidney
one
dog
detect
kidney
one
dog
level
bdefensin
lymphoid
tissu
kidney
low
mrna
detect
tissu
dog
tissu
sampl
neg
assess
use
convent
pcr
number
b
bronchiseptica
averag
reduc
follow
incub
mgml
follow
incub
mgml
fig
treatment
mgml
affect
bacteri
viabil
addit
nacl
total
concentr
mm
mm
prevent
antibacteri
effect
b
bronchiseptica
peptid
concentr
mgml
mgml
bdefensin
compon
innat
immun
respons
import
protect
mucos
surfac
respiratori
tract
microbi
invas
human
presenc
regul
bdefensin
airway
epitheli
cell
studi
extens
schutt
mccray
singh
et
al
tsutsumiishii
nagaoka
howev
one
canin
bdefensin
shown
present
lung
sang
et
al
present
studi
therefor
assess
presenc
four
bdefensin
canin
respiratori
tract
three
found
present
canin
tracheal
sampl
primari
tracheal
epitheli
cell
treatment
cell
lp
lead
increas
bdefensin
product
contrast
studi
speci
bdefensin
found
upregul
epitheli
cell
follow
incub
lp
level
human
bdefensin
increas
vagin
epitheli
cell
lp
treatment
pivarcsi
et
al
product
bovin
tracheal
antimicrobi
peptid
tap
induc
lp
tracheal
epitheli
cell
diamond
et
al
upregul
thought
mediat
tolllik
receptor
via
nfkb
pathway
froy
addit
treatment
epitheli
cell
inflammatori
mediat
tnfa
shown
induc
bdefensin
product
diamond
et
al
harder
et
al
tsutsumiishii
nagaoka
concentr
lp
mg
ml
use
present
studi
base
previou
experi
use
tracheal
organ
cultur
dose
led
upregul
proinflammatori
mediat
priestnal
et
al
tnfa
inde
upregul
ctec
follow
lp
treatment
time
point
test
result
therefor
indic
canin
bdefensin
may
regul
via
tracheal
epitheli
cell
possibl
differ
signal
pathway
respons
activ
defensin
addit
cell
type
lymphocyt
macrophag
present
respiratori
tract
absent
cultur
epitheli
cell
may
necessari
induc
defensin
product
studi
assess
effect
supernat
lpsstimul
sever
studi
analys
effect
viral
infect
product
defensin
human
shown
induc
product
primari
bronchial
epitheli
cell
proud
et
al
viral
replic
essenti
effect
conclud
upregul
mediat
intracellular
doublestrand
viral
rna
express
human
bdefensin
also
increas
respiratori
papilloma
compar
control
tissu
chong
et
al
sheep
bdefensin
upregul
lung
neonat
lamb
follow
experiment
infect
ovin
parainfluenza
viru
type
grubor
et
al
wherea
infect
bovin
respiratori
syncyti
viru
significantli
increas
express
defensin
kawashima
et
al
mice
infect
influenza
viru
led
increas
express
murin
bdefensin
respiratori
tract
chong
et
al
studi
crcov
cpiv
fail
induc
express
canin
bdefensin
despit
virus
produc
doublestrand
rna
intermedi
replic
bdefensin
level
instead
reduc
time
point
downregul
bdefensin
lung
pig
recent
report
follow
experiment
infect
porcin
reproduct
respiratori
syndrom
viru
sang
et
al
moreov
shown
crcovinfect
tracheal
organ
cultur
exhibit
decreas
level
proinflammatori
cytokin
tnfa
compar
control
cultur
priestnal
et
al
mechan
appar
downregul
known
howev
may
involv
disrupt
signal
necessari
determin
crcov
cpiv
infect
abl
prevent
defensin
upregul
mediat
howev
mediat
remain
determin
canin
defensin
clear
observ
downregul
bdefensin
follow
challeng
lp
virus
biolog
signific
show
signific
reduct
copi
number
howev
mrna
level
untreat
epitheli
cell
low
uncertain
reduct
would
affect
abil
cell
prevent
microbi
infect
addit
tracheal
sampl
bdefensin
also
detect
tissu
includ
skin
lymphoid
tissu
kidney
tissu
distribut
appear
similar
ortholog
harder
et
al
candil
et
al
report
express
canin
skin
abl
detect
studi
level
skin
low
detect
tissu
sampl
test
previous
report
present
skin
although
express
variabl
wingat
et
al
level
mrna
tissu
sampl
test
present
studi
may
elev
due
inflammatori
process
sampl
dog
euthanis
due
behaviour
problem
clinic
data
avail
absenc
clinic
respiratori
diseas
moreov
variabl
express
may
due
sampl
differ
area
within
one
tissu
antimicrobi
activ
assess
respiratori
pathogen
b
bronchiseptica
peptid
shown
significantli
reduc
number
viabl
bacteria
incub
one
hour
inhibitori
concentr
determin
studi
higher
determin
rang
bacteria
harder
et
al
howev
b
bronchiseptica
shown
resist
treatment
antimicrobi
peptid
bacteria
banemann
et
al
data
avail
effect
canin
bdefensin
b
bronchiseptica
similar
studi
use
obtain
minimum
inhibitori
concentr
mgml
gramneg
pathogen
canin
urogenit
tract
mgml
gramposit
pathogen
sang
et
al
studi
shown
present
high
level
canin
upper
respiratori
tract
antibacteri
activ
toward
import
caus
respiratori
diseas
dog
complex
respiratori
diseas
cird
requir
novel
approach
prevent
treatment
may
candid
develop
topic
treatment
upper
respiratori
tract
possibl
drawback
howev
salt
sensit
physiolog
nacl
concentr
mm
similar
bdefensin
maisetta
et
al
sang
et
al
nacl
concentr
human
airway
surfac
fluid
shown
serum
knowl
et
al
smith
et
al
howev
factor
presenc
protein
may
also
interfer
activ
defensin
maisetta
et
al
therefor
remain
determin
canin
bdefensin
activ
condit
found
upper
respiratori
tract
vivo
present
lower
level
compar
clear
play
role
defenc
canin
tracheal
epithelium
howev
well
may
import
innat
immun
respons
skin
